Alemtuzumab-associated diffuse alveolar damage – a case report

Identifying causes of alemtuzumab induced respiratory symptoms in Multiple Sclerosis (MS) patients is crucial.

Source: BMC Neurology - September 23, 2020 Category: Neurology Authors: Antonios Bayas, Martina Menacher, Martin Schwaiblmair, Bruno M ärkl and Markus Naumann Tags: Case report Source Type: research